Insider · CIK 0001265784
William R Larue
Files at ONCT (Oncternal Therapeutics, Inc.), TCON (Tracon Pharmaceuticals, Inc.). First filing Jan 19, 2023, latest Jan 19, 2023.
In brief
William R Larue files SEC Form 4 as director at TCON (Tracon Pharmaceuticals, Inc.), and also at ONCT (Oncternal Therapeutics, Inc.). Since Jan 19, 2023, William R Larue has reported 0 open-market buys worth $0 and 1 open-market sell worth $151, the latest filed on Jan 19, 2023.
A track record needs three past buys with six months of prices behind them; William R Larue has 0, so none is measured yet.
The newest scored trade: sold $151 of TCON on Dec 21, 2022, filed Jan 19, 2023, scored 15 (weak).
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 15Weak | TCONsell Tracon Pharmaceuticals, Inc. | $151 120 shares | -2% | - |
Transactions
Every row this insider has filed, 4 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 20, 2024 | ONCT Oncternal Therapeutics, Inc. | AGrant or award Stock Optionsderivative | +2,200 | $0.00 | $0 | 2,200 | Jun 24, 2024 |
| Jun 28, 2023 | ONCT Oncternal Therapeutics, Inc. | AGrant or award Stock Optionsderivative | +25,000 | $0.00 | $0 | 25,000 | Jun 30, 2023 |
| Apr 19, 2023 | TCON Tracon Pharmaceuticals, Inc. | AGrant or award Director Stock Option (Right to Buy)derivative | +18,000 | $0.00 | $0 | 18,000 | Apr 21, 2023 |
| Dec 21, 2022 | TCON Tracon Pharmaceuticals, Inc. | SOpen-market sale Common Stock | -120 | $1.26 | $151 | 7,763 | Jan 19, 2023 |
Questions about William R Larue
Answered from the filings on this page, as of the latest one.
Is William R Larue buying or selling?
Not in the last 12 months. William R Larue's latest open-market trade on SEC Form 4 was sold $151 of TCON on Dec 21, 2022.
How did William R Larue's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and William R Larue has 0.
Where does William R Larue file Form 4?
William R Larue has filed Form 4 at TCON (Tracon Pharmaceuticals, Inc.); ONCT (Oncternal Therapeutics, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.